Grifols ADR Earnings, Revenue miss in Q4

Investing.com

_news_article_title_published Feb 28, 2022 23:22

Investing.com - Grifols ADR reported on Monday fourth quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.

Grifols ADR announced earnings per share of €0.1134 on revenue of €1.54B. Analysts polled by Investing.com anticipated EPS of €0.3151 on revenue of €1.57B.

Grifols ADR shares are up 3.56% from the beginning of the year and are trading at €11.63 , down-from-52-week-high.They are outperforming the Nasdaq which is down 12.47% from the start of the year.

h2 Grifols ADR follows other major Healthcare sector earnings this month/h2

Grifols ADR's report follows an earnings matched by Roche Holding ADR on Thursday, February 3, 2022, who reported EPS of €1.29 on revenue of €17.54B, compared to forecasts EPS of €1.29 on revenue of €17.1B.

Pfizer had beat expectations on Tuesday, February 8, 2022 with fourth quarter EPS of €1.08 on revenue of €23.84B, compared to forecast for EPS of €0.8742 on revenue of €24.16B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

_newTouch_app_install_inline_banner_title
_newTouch_app_install_inline_banner_text
_newTouch_app_install_inline_banner_button

_touchRiskDisclosure_message

_Logout
Mobile_app_sign_in_pop_up_sign_out_text
_No_Yes
_Cancel_Yes
mobile_app_saving_changes